Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Aytu Biopharma (AYTU) Long-Term Debt Issuances (2020 - 2022)

Aytu Biopharma (AYTU) has disclosed Long-Term Debt Issuances for 8 consecutive years, with -$73.9 million as the latest value for Q1 2022.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to -$73.9 million in Q1 2022 year-over-year; TTM through Jun 2022 was $15.0 million, a N/A change, with the full-year FY2025 number at $1.9 million, down 85.72% from a year prior.
  • Long-Term Debt Issuances was -$73.9 million for Q1 2022 at Aytu Biopharma, down from $46.6 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $46.6 million in Q4 2021 to a low of -$73.9 million in Q1 2022.
  • A 3-year average of $3.6 million and a median of $2.5 million in 2020 define the central range for Long-Term Debt Issuances.